Log in with your email address username.


[Correspondence] Favipiravir—a prophylactic treatment for Ebola contacts?

Since the Ebola outbreak began in March, 2014, 25 178 cases of Ebola have been reported.1 To control spread of Ebola in west African communities, vaccination campaigns have been proposed. However, the efficacy of candidate Ebola vaccines for primary prevention has not been proven.2 Furthermore, in communities in which Ebola transmission might be ongoing, an important question is: how will such a vaccination be perceived if a vaccinated person develops Ebola? Such a scenario is possible in people who contract Ebola virus before vaccination.